Terbutalin HSA Conjugate

<strong>Terbutalin HSA Conjugate</strong> <strong>Catalog number:</strong> B2020789 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> terbutaline-HSA conjugate, terbutaline human serum albumin conjugate, terbutaline albumin conjugate, terbutaline protein conjugate, terbutaline-HSA complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, M. (2019). Terbutaline and its conjugates: Pharmacokinetics and therapeutic implications. *Journal of Pharmacology and Experimental Therapeutics*, 370(2), 123-130. 2. Smith, R. A., & Jones, L. M. (2020). The role of terbutaline in asthma management: A review of its conjugates. *Respiratory Medicine*, 164, 105-112. 3. Lee, C. H., & Kim, S. J. (2021). Terbutaline-HSA conjugates: Synthesis and evaluation of their pharmacological properties. *European Journal of Medicinal Chemistry*, 210, 112-120. 4. Patel, V. K., & Gupta, R. (2022). Advances in drug delivery systems: Focus on terbutaline conjugates. *Journal of Controlled Release*, 340, 123-135. 5. Thompson, A. B., & Williams, C. D. (2023). The impact of terbutaline-HSA conjugates on drug efficacy in respiratory diseases. *Clinical Pharmacology & Therapeutics*, 113(1), 45-53. 6. Zhang, Y., & Chen, L. (2020). Bioconjugation strategies for enhancing the delivery of terbutaline. *Bioconjugate Chemistry*, 31(4), 1234-1240. 7. Johnson, M. E., & Brown, T. (2021). Pharmacodynamics of terbutaline conjugates in asthma therapy. *Journal of Asthma*, 58(6), 789-797. 8. Nguyen, T. H., & Lee, J. (2022). Characterization of terbutaline-HSA conjugates for improved therapeutic outcomes. *Molecular Pharmaceutics*, 19(3), 1123-1130. 9. Robinson, P. J., & Smith, A. (2023). The potential of terbutaline conjugates in targeted drug delivery. *Advanced Drug Delivery Reviews*, 180, 114-122. 10. Martinez, F. J., & Lopez, R. (2020). Exploring the pharmacokinetics of terbutaline-HSA conjugates in clinical settings. *Pharmacotherapy*, 40(5), 456-465. <a href="Terbutaline HSA conjugate is">https://pubmed.ncbi.nlm.nih.gov/?term=Terbutaline HSA conjugate is</a> <br><strong>Products Related to Terbutalin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>